Joseph C. Papa

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Gaithersburg, MD
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Charles Schoch, as Attorney-In-Fact for Joseph C. Papa
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joseph C. Papa

Form 4 holding CEO & Chairman, Director

Bausch & Lomb Corp

Security class
Non-Qualified Stock Options (right to purchase)
Shares / value
1,868,131
Estimated value
$29,628,558
Report date
05 May 2022
Price
$15.86
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
Form 4 holding Director

Bausch Health Companies Inc.

Security class
Common Shares, No Par Value
Shares / value
1,427,568
Estimated value
$11,449,095
Report date
10 May 2022
Price
$8.02
Ownership
Direct
Form 4 holding CEO & Chairman, Director

Bausch & Lomb Corp

Security class
Common Shares, No Par Value
Shares / value
472,222
Estimated value
$8,056,107
Report date
05 May 2022
Price
$17.06
Ownership
Direct
Form 4 holding President and CEO, Director

Emergent BioSolutions Inc.

Security class
Employee Stock Option (Right to buy)
Shares / value
1,784,694
Estimated value
Report date
03 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Emergent BioSolutions Inc.

Security class
Employee Stock Options (Right to Buy)
Shares / value
1,532,500
Estimated value
Report date
12 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Bausch Health Companies Inc.

Security class
Restricted Share Units
Shares / value
0
Estimated value
Report date
10 May 2022
Price
$9.40
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
Form 4 holding Director

Prometheus Biosciences, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
16 Jun 2023
Price
$108.42
Ownership
By The Papa Family Charitable Trust
Form 4 holding Director

Prometheus Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
16 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Joseph C. Papa

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .